Dec. 18 at 3:00 AM
$SRTA The Organ Transplant System Improvement Act, introduced by Senator Ron Wyden on December 17, 2025 impact for SRTA, this bill is a potential "super-catalyst." While it introduces regulatory pressure, it directly incentivizes the exact services Strata provides: high-efficiency logistics and advanced clinical organ preservation.
New Organ Procurement Organizations (OPOs).
Currently, OPOs are regional monopolies. If the bill passes, we could see new, more aggressive OPOs enter the market. Strata acts as the "infrastructure layer" for these organizations. New OPOs are unlikely to build their own fleet of planes or perfusion labs from scratch; they will likely outsource those needs to a turnkey provider like Strata.
National Performance Standards & Penalties.
Wyden’s bill proposes strict nationwide standards for OPOs, with "stronger penalties" for those with high organ discard rates.
The Impact on SRTA: This is the most direct tailwind for Strata's Clinical Services (Perfusion).
